IQVIA Biotech

Videos

R&D growth from biotech and emerging biopharma companies is strong. With that comes a transformation of the end-to-end services needed to meet the strategic, clinical, and operational needs of these smaller companies. Join this podcast to learn about clinical development and outsourcing trends that emerged in 2021 and a discussion of what to expect in 2022.

Trends in Biotech Clinical Development with Dr. Chris Smyth

Trends in Biotech Clinical Development

Podcasts

Trends in Biotech Clinical Development Podcast

https://www.appliedclinicaltrialsonline.com/act_w/biotech_journey

Biotech and biopharma companies continue to drive the drug development pipeline, and despite a global pandemic, many small, nimble sponsors remain strong in funding levels and drug approvals. Still, with increased investment in the biotech sector, competition for visibility and resources is fierce.

For many small sponsors, the number of questions to ask and decisions to make can be overwhelming. Leveraging data and expertise to support a strategic drug development plan can mean the difference between success and failure.

Join this webinar to learn how to approach the early stages of drug development and build a long-term plan to advance your drug to market.

Gain tips on how to avoid the pitfalls of early clinical development

Discover insights from a team with experience leading hundreds of biotech programs

Learn how to build a clinical development strategy aligned to regulatory, payer, and commercial requirements

Megan Hooton brings a wealth of operational and cross-cultural expertise to the role of Chief Operating Officer at IQVIA Biotech, having more than 30 years of experience managing global research and development operations across pharmaceutical and biotech segments.

Meg joined IQVIA in 2008 and has served in clinical operations and project management roles, initially in her native Australia, and later managed the North Asia Therapeutic Delivery Unit. She served as Vice President and Head of Global Project Leadership and Regulatory Start-up for the Asia-Pacific region before becoming the Global Therapeutic Area Head for Oncology in 2017.

Meg started her career as a Registered Nurse, and after stints in the private sector, academia, and the Royal Australian Navy Reserve, she joined the clinical team at Bristol-Myers Squibb in the oncology and immunology franchises. In addition to her nursing degree and specialization in Intensive Care and Coronary Care, Meg has a bachelor's degree in Asian Studies from Monash University.


Vice President and Global Head of the Strategic Drug Development Group
IQVIA

Michael Kardas, PharmD is Vice President and Global Head of the Strategic Drug Development Group at IQVIA. Dr. Kardas has more than 20 years of experience in the biopharma industry and provides expert advice to biopharmaceutical companies in the data driven design and development of their clinical program. He earned his B.A. degree in Biology from College of the Holy Cross and completed his Doctor of Pharmacy degree from the University of Connecticut.

Webcasts

Wednesday December 8, 2021 at 11am EST | 8am PST | 4pm GMT | 5pm CET 
Join this webinar to learn how to approach the early stages of drug development and build a long-term plan to advance your drug to market. 

Embarking on the biotech journey: how to build a long-term plan for successful drug development

http://www.appliedclinicaltrialsonline.com/act_w/insights

	A record number of new oncology drugs have been approved in recent years, bringing new treatment options to patients. However, despite robust levels of pipeline activity, oncology trials are complex and remain a challenging area for research and development. 

	Join this webinar to learn about trends shaping the development and delivery of cancer treatment worldwide. We will share insights and best practices to help ensure your future oncology trials are designed to be quick and efficient and yield high-quality data for the best chance of success. Our experts will address specific considerations for biotech companies embarking on oncology trials.

			Understand top trends driving change in oncology clinical development today and through 2023.

			Recognize the impact of new therapies and care standards on trial planning and design.

			Learn how to apply real world evidence to trial design, trial start-up, and trial conduct for more efficient and effective trials.

Murray Aitken, Executive Director, IQVIA Institute for Human Data Science

	Andrew Zupnick, Ph.D., Vice President, Oncology Strategy, IQVIA Biotech

	On demand available after airing until Nov. 12, 2020.

This complimentary webinar explores top trends influencing oncology clinical development. We will share insights and best practices to help ensure your future oncology trials are designed to be quick and efficient and yield high quality data for the best chance for success.  
Live: Tuesday, November 12, 2019 at 10am EST
On demand available after airing until Nov. 12, 2020.
Register free

IQVIA Biotech

Articles

Trends in Biotech Clinical Development with Dr. Chris Smyth

Trends in Biotech Clinical Development

Trends in Biotech Clinical Development Podcast

Embarking on the biotech journey: how to build a long-term plan for successful drug development

Trends and Insights for Your Oncology Trial: Considerations for biotech companies embarking on oncology clinical trials